Companies on Multiple Myeloma in Europe

Published within

« | 1 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Genmab A/S

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 157 people as of December 31, 2013.

Published By MarketLine
05 Jan 2015 $175
Buy

« | 1 | » »|

No help is available.